Search
for
Sort by
Research 781–810 of 1000+
- Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases
- [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Functional histopathology of keloid disease.
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*
- Adult Kawasaki Disease: Report of Two Cases and Literature Review
- MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
- Treatment of Skin Disease: Comprehensive Therapeutic Strategies
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Perspectives of Kennedy's disease
- MULTIPLE DEFECTS OF THE HAIR SHAFT IN NETHERTON'S DISEASE.
- Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study
- Baldness and coronary artery disease: the dermatologic point of view of a controversial issue.
- Is seborrhea a sign of autonomic impairment in Parkinson's disease?
- Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
- THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Androgenetic alopecia and coronary artery disease in women
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- Depth and Patterns of Adnexal Involvement in Primary Extramammary (Anogenital) Paget Disease: A Study of 178 Lesions From 146 Patients
- Management of ‘refractory’ skin disease in patients with lupus erythematosus
- Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis
- Commentary: Darier-White Disease
- Androgenetic alopecia and risk of coronary artery disease
- Psychological aspects of hair disease
- Hyperadrenocorticism (Hyperadrenocorticoidism, Hyperadrenocorticalism, Cushing’s Disease, Cushing’s Syndrome)
- MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary amenorrhea and female delayed puberty